drugset / Trial / NCT00821444
Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
RandomizedCrossoverOpen-labelBasic science
Summary
Commercial ziprasidone capsules show a large increase in bioavailability with food. The formulation tested in this study aims to reduce or eliminate that increase.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | B16 | Unknown | 40 mg | — |
| Comparator | Ziprasidone | Small molecule | 40 mg | — |
Indications
No indication recorded.